Service Tax Additional
select a format
Recent Viewed Reports
Why Ken Reasearch?
This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"
I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"
While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"
We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"
The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"
Timetric's "Catalent, Inc. : Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, key competitors, financial analysis, recent developments, key employees, company locations and subsidiaries as well as employee biographies.
This report is a crucial resource for industry executives and anyone looking to access key information about "Catalent, Inc."
The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Examines and identifies key information and issues about "Catalent, Inc." for business intelligence requirements.
Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
The profile also contains information on business operations, company history, major products and services, key employees, and locations and subsidiaries.
Reasons to Buy
Quickly enhance your understanding of "Catalent, Inc."
Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.
Increase business/sales activities by understanding your competitors' businesses better.
Recognize potential partnerships and suppliers.
Catalent, Inc. (Catalent) provides development solutions for drugs, consumer health products and biologics and advanced delivery technologies. Its portfolio of products and services includes biologics, oral technologies, inhalation technologies, development solutions, consumer health products, sterile technologies and clinical supply services. In addition, it manufactures vegicaps capsule, optigel mini capsules, twist off capsules, dry powder inhalers, nasal sprays and prefilled syringes. The company produces over 70 billion doses annually for approximately 7,000 customer products. It holds nearly 1,300 patents and patent applications. The company has presence in Asia-Pacific, Europe, Latin America and North America. Catalent is headquartered in Somerset, New Jersey, the US.
1 Catalent, Inc. - Business Analysis
1.1 Catalent, Inc. - Company Overview
1.2 Catalent, Inc. - Business Description
1.3 Catalent, Inc. - Major Products and Services
2 Catalent, Inc. - Analysis of Key Performance Indicators
2.1 Catalent, Inc. - Five Year Snapshot: Overview of Financial and Operational Performance Indicators
2.2 Catalent, Inc. - Key Financial Performance Indicators
2.2.1 Catalent, Inc. - Revenue and Operating Profit
2.2.2 Catalent, Inc. - Asset and Liabilities
2.2.3 Catalent, Inc. - Net Debt vs. Gearing Ratio
2.2.4 Catalent, Inc. - Solvency
2.2.5 Catalent, Inc. - Valuation
2.3 Catalent, Inc. - Key Competitors
3 Catalent, Inc. - Recent Developments
4 Catalent, Inc. - SWOT Analysis
4.1 Catalent, Inc. - SWOT Analysis - Overview
4.2 Catalent, Inc. - Strengths
4.3 Catalent, Inc. - Weaknesses
4.4 Catalent, Inc. - Opportunities
4.5 Catalent, Inc. - Threats
5 Catalent, Inc. - Company Statement
6 Catalent, Inc. - History
7 Catalent, Inc. - Key Employees
8 Catalent, Inc. - Key Employee Biographies
9 Catalent, Inc. - Locations and Subsidiaries
9.1 Catalent, Inc. - Head Office
9.2 Catalent, Inc. - Other Locations and Subsidiaries
10.2 Ratio Definitions
Figure 1: Catalent, Inc. - Revenue and Operating Profit
Figure 2: Catalent, Inc. - Financial Position
Figure 3: Catalent, Inc. - Net Debt vs. Gearing Ratio
Figure 4: Catalent, Inc. - Solvency
Figure 5: Catalent, Inc. - Valuation
Table 1: Catalent, Inc. - Major Products and Services
Table 2: Catalent, Inc. - Key Ratios - Annual
Table 3: Catalent, Inc. - Key Ratios - Interim
Table 4: Catalent, Inc. - Key Capital Market Indicators
Table 5: Catalent, Inc. - History
Table 6: Catalent, Inc. - Key Employees
Table 7: Catalent, Inc. - Key Employee Biographies
Table 8: Catalent, Inc. - Subsidiaries
Table 9: Catalent, Inc. - Locations
Single User License:
Corporate User License:
Catalent, Inc., United States, Pharmaceuticals and Healthcare, Timetric, company overview, key facts, business description, SWOT analysis, strengths, weaknesses, opportunities, threats, mergers & acquisitions, key employees, competitive benchmarking, employee biographies & locations and subsidaries.